OBJECTIVES: To provide a comprehensive estimate of the societal costs of Taenia solium cysticercosis for the Eastern Cape Province (ECP), South Africa, as an objective measure of its impact in this endemic area. METHODS: Epidemiological data on the prevalence of epilepsy, proportion of epilepsy cases due to neurocysticercosis (NCC) and consequences of cysticercosis were gathered from published and unpublished sources. Economical data were mostly obtained from governmental sources. Three methods were used for estimating productivity losses. Monte Carlo sampling was used to represent the uncertainty of the estimates with 95% Credible Intervals (95% CI). The estimation is for 1 year using a societal approach. All costs are reported in 2004 US Dollars. RESULTS: Overall, there were an estimated 34 662 (95% CI: 17 167-54 068) NCC-associated cases of epilepsy in ECP in 2004. The overall monetary burden (in million of US Dollars) was estimated to vary from US Dollars 18.6 (95% CI: US Dollars 9.0-32.9) to US Dollars 34.2 (95% CI: US Dollars 12.8-70.0) depending on the method used to estimate productivity losses. The agricultural sector contributed an average of Dollars 5.0 million. The prevalence of epilepsy, proportion of productivity reduction and the proportion of epilepsy cases attributable to NCC had the largest impact on the overall estimates. CONCLUSION: This preliminary estimate suggests that T. solium cysticercosis results in considerable monetary costs to a region that is already economically constrained. Because this infection is preventable, these results could guide stakeholders in deciding where to invest scarce health and agricultural resources in their countries.
OBJECTIVES: To provide a comprehensive estimate of the societal costs of Taenia solium cysticercosis for the Eastern Cape Province (ECP), South Africa, as an objective measure of its impact in this endemic area. METHODS: Epidemiological data on the prevalence of epilepsy, proportion of epilepsy cases due to neurocysticercosis (NCC) and consequences of cysticercosis were gathered from published and unpublished sources. Economical data were mostly obtained from governmental sources. Three methods were used for estimating productivity losses. Monte Carlo sampling was used to represent the uncertainty of the estimates with 95% Credible Intervals (95% CI). The estimation is for 1 year using a societal approach. All costs are reported in 2004 US Dollars. RESULTS: Overall, there were an estimated 34 662 (95% CI: 17 167-54 068) NCC-associated cases of epilepsy in ECP in 2004. The overall monetary burden (in million of US Dollars) was estimated to vary from US Dollars 18.6 (95% CI: US Dollars 9.0-32.9) to US Dollars 34.2 (95% CI: US Dollars 12.8-70.0) depending on the method used to estimate productivity losses. The agricultural sector contributed an average of Dollars 5.0 million. The prevalence of epilepsy, proportion of productivity reduction and the proportion of epilepsy cases attributable to NCC had the largest impact on the overall estimates. CONCLUSION: This preliminary estimate suggests that T. soliumcysticercosis results in considerable monetary costs to a region that is already economically constrained. Because this infection is preventable, these results could guide stakeholders in deciding where to invest scarce health and agricultural resources in their countries.
Authors: V Schmidt; C S Sikasunge; E Odongo-Aginya; C Simukoko; G Mwanjali; S Alarakol; E Ovuga; W Matuja; C Kihamia; T Löscher; A S Winkler; G Bretzel Journal: Afr Health Sci Date: 2015-03 Impact factor: 0.927
Authors: Adnan Ali Khan Choudhury; James V Conlan; Vanessa Nadine Racloz; Simon Andrew Reid; Stuart D Blacksell; Stanley G Fenwick; Andrew R C Thompson; Boualam Khamlome; Khamphouth Vongxay; Maxine Whittaker Journal: Ecohealth Date: 2013-02-16 Impact factor: 3.184
Authors: Jin-Mei Xu; Luz P Acosta; Min Hou; Daria L Manalo; Mario Jiz; Blanca Jarilla; Archie O Pablo; Remigio M Ovleda; Gretchen Langdon; Stephen T McGarvey; Jonathan D Kurtis; Jennifer F Friedman; Hai-Wei Wu Journal: J Trop Med Date: 2010-03-29
Authors: Nicolas Praet; Kirezi Kanobana; Constantin Kabwe; Vivi Maketa; Philippe Lukanu; Pascal Lutumba; Katja Polman; Peter Matondo; Niko Speybroeck; Pierre Dorny; Julienne Sumbu Journal: PLoS Negl Trop Dis Date: 2010-09-07